Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 220.71M P/E - EPS this Y 4.90% Ern Qtrly Grth -
Income -68.17M Forward P/E -2.98 EPS next Y 13.50% 50D Avg Chg -17.00%
Sales 9.16M PEG - EPS past 5Y - 200D Avg Chg 19.00%
Dividend N/A Price/Book 1.40 EPS next 5Y - 52W High Chg -32.00%
Recommedations 1.40 Quick Ratio 12.35 Shares Outstanding 48.26M 52W Low Chg 169.00%
Insider Own 7.00% ROA -25.87% Shares Float 17.90M Beta 0.33
Inst Own 100.49% ROE -43.04% Shares Shorted/Prior 1.39M/1.12M Price 5.22
Gross Margin - Profit Margin - Avg. Volume 109,916 Target Price 8.33
Oper. Margin -3,324.43% Earnings Date May 13 Volume 105,808 Change -2.06%
About Ikena Oncology, Inc.

Ikena Oncology, Inc. operates as an oncology company that develops differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the United States. Its lead program is IK-930, an internally discovered, oral, TEAD1-selective, small molecule inhibitor of the Hippo pathway. The company also develops IK-595, a molecular glue designed to trap MEK and RAF in an inactive complex. Ikena Oncology, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Ikena Oncology, Inc. News
04/10/24 Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum
03/14/24 Ikena Oncology Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
03/12/24 Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
02/27/24 Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference
02/21/24 Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer
02/14/24 Down -29.05% in 4 Weeks, Here's Why Ikena Oncology, Inc. (IKNA) Looks Ripe for a Turnaround
01/24/24 Down -33.01% in 4 Weeks, Here's Why Ikena Oncology, Inc. (IKNA) Looks Ripe for a Turnaround
01/19/24 Ikena Oncology to lay off 35% of staff
01/18/24 Ikena Oncology Outlines Key Priorities and Provides Corporate Updates
11/10/23 Broker Revenue Forecasts For Ikena Oncology, Inc. (NASDAQ:IKNA) Are Surging Higher
11/09/23 Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results
11/07/23 Ikena Oncology to Present at Multiple November 2023 Investor Conferences
09/27/23 Pliant Therapeutics, Inc. (PLRX) Soars 14.3%: Is Further Upside Left in the Stock?
07:00 AM Ikena Oncology to Participate in September 2023 Investor Conferences
08/12/23 Downgrade: Here's How Analysts See Ikena Oncology, Inc. (NASDAQ:IKNA) Performing In The Near Term
08/10/23 Ikena Oncology, Inc. (IKNA) Reports Q2 Loss, Lags Revenue Estimates
08/10/23 Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate Update
08/08/23 Loss-making Ikena Oncology (NASDAQ:IKNA) sheds a further US$11m, taking total shareholder losses to 22% over 1 year
08/07/23 Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction
06/20/23 Recent Price Trend in Ikena Oncology, Inc. (IKNA) is Your Friend, Here's Why
IKNA Chatroom

User Image DeepDown Posted - 1 day ago

$IKNA This one is sitting with 275M cash witn mc at 64M. its targeting the hippo pathway and very important . Also has another platform targeting mek and ras. Its going to be huge. $PYXS, $CTMX $ELYM https://www.nature.com/articles/s41392-022-01191-9

User Image BiotechSwingz Posted - 1 day ago

$IKNA buying here. Full with quality tutes and way under cash.

User Image YorubaTwits Posted - 04/28/24

$IKNA this will do so well this year

User Image Doorkey Posted - 04/26/24

$CGEM Oncology pharm trending. No love for $IKNA

User Image Jonathanthewiz Posted - 04/23/24

$IKNA oh no it’s going down everyone sell

User Image Jonathanthewiz Posted - 04/23/24

$IKNA whoever is loading up chill out I’m trying to get in at a better price

User Image ButterCapital Posted - 04/18/24

$IKNA accumulating

User Image YorubaTwits Posted - 04/10/24

$IKNA ouch do better

User Image Stock_Titan Posted - 04/10/24

$IKNA Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum https://www.stocktitan.net/news/IKNA/ikena-oncology-to-present-at-the-stifel-2024-virtual-targeted-g6a65nq3u95x.html

User Image RallyRaider Posted - 04/07/24

$IKNA lot of cash on board and saw some nice accumulation. why is it not going anywhere?

User Image elbowcrooker Posted - 1 month ago

$IKNA loading the boat

User Image Hoidzaheer Posted - 1 month ago

$BAOS $CAMP $IKNA $LIDR $MDAI

User Image Streetbullx2 Posted - 03/28/24

$AKBA i live in miami beach, today i get miami beach drunk. paytience is key when the science is outstanding next $CLRB $IKNA $IOBT PDSB TPST CKPT

User Image Streetbullx2 Posted - 03/27/24

$AKBA me tomorrow and in the future with my next quality plays $CLRB $PDSB $IKNA $IOBT

User Image elbowcrooker Posted - 03/26/24

$IKNA good spot for entry

User Image Kassianys Posted - 03/25/24

$IKNA Remember! PT 8$ minimum !

User Image Streetbullx2 Posted - 03/21/24

$AKBA $GERN $ADAP $IKNA FIRE SALE, ridiculous prices these are a 2X-5X easy if everything come together IKNA and ADAP are full of cash they should not be trading at these prices. always do your DD and dont put all your eggs in one basket

User Image MadHatterTrades74 Posted - 03/21/24

$IKNA I cannot tell if this 1.2 mil share was a buy or sell😡

User Image Doorkey Posted - 03/21/24

$SVRA $RZLT $IKNA My favorites under five.

User Image BiotechSwingz Posted - 03/19/24

$IKNA HC Wainwright & Co. Reiterates Buy on Ikena Oncology, Maintains $11 Price Target https://newsfilter.io/a/30d437a8eb26c01c2c6843c64c6f030a

User Image BinTraden Posted - 03/14/24

$IKNA I've had this one on watch for a while and finally made a starter buy today, great fundamentals as @BiotechSwingz mentioned with well over $3/sh cash, high insider ownership 47%, and low short interest, would like higher institutional % but the insider ownership makes up for that for me, just keep some powder on the side for any dips.

User Image BiotechSwingz Posted - 03/14/24

$IKNA

User Image Smith3_1 Posted - 03/14/24

$IKNA https://twitter.com/GrantedPatents/status/1768292586630864968?t=Jr9GLUtqwGQYFbi6p1N9tA&s=19

User Image BiotechSwingz Posted - 03/13/24

$IKNA added some here. nice cash and tutes. burn lowered. nice setup.

User Image elbowcrooker Posted - 03/12/24

$IKNA starter

User Image Stock_Titan Posted - 03/12/24

$IKNA Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results https://www.stocktitan.net/news/IKNA/ikena-oncology-reports-fourth-quarter-and-full-year-2023-financial-7z5zl07fzye9.html

User Image RallyRaider Posted - 03/10/24

$IKNA higher lows and pleas also see accumulation bars--- is about to pop

User Image Doorkey Posted - 03/08/24

$IKNA Holding.

User Image RallyRaider Posted - 03/08/24

$IKNA very beautiful bars off the bottom with higher lows

User Image vmslbdibIumzgzjoch Posted - 03/07/24

@Wealwayswin2024 $IKNA $TNON you get in this?

Analyst Ratings
HC Wainwright & Co. Buy Mar 19, 24
HC Wainwright & Co. Buy Mar 12, 24
Wedbush Outperform Jan 19, 24
HC Wainwright & Co. Buy Jan 19, 24
HC Wainwright & Co. Buy Nov 9, 23
Wedbush Outperform Sep 22, 23
HC Wainwright & Co. Buy Aug 10, 23
HC Wainwright & Co. Buy Aug 7, 23
HC Wainwright & Co. Buy May 24, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
ORBIMED ADVISORS LLC Director Director Jun 22 Buy 4.25 252,225 1,071,956 2,098,097 06/24/22
Bonita David P Director Director Jun 22 Buy 4.25 252,225 1,071,956 2,098,097 06/24/22
Zhang Xiaoyan Michelle Chief Scientific Off.. Chief Scientific Officer Jan 10 Option 2.15 1,000 2,150 45,439 01/12/22
Zhang Xiaoyan Michelle Chief Scientific Off.. Chief Scientific Officer Jan 10 Sell 12 1,000 12,000 44,475 01/12/22
Zhang Xiaoyan Michelle Chief Scientific Off.. Chief Scientific Officer Dec 10 Option 2.15 1,000 2,150 45,475 12/14/21
Zhang Xiaoyan Michelle Chief Scientific Off.. Chief Scientific Officer Dec 10 Sell 14.76 1,000 14,760 44,475 12/14/21
FORMELA JEAN FRANCOIS Director Director Mar 30 Buy 16 125,000 2,000,000 874,634 12/14/21
FORMELA JEAN FRANCOIS Director Director Mar 30 Sell 14.56 26,278 382,608 1,241,935 12/14/21
Atlas Venture Fund XI, L.P. 10% Owner 10% Owner Mar 30 Buy 16 125,000 2,000,000 874,634 12/14/21
Atlas Venture Fund XI, L.P. 10% Owner 10% Owner Mar 30 Sell 14.56 26,278 382,608 1,241,935 12/14/21